With the support of our research and development program, Pherros Biosciences has the infrastructure and expertise to bring novel therapeutics to market.
Our focus is to research and develop novel medicines and therapeutics to improve people’s lives
on a global scale. Our commitment spans a wide array of subject matter and, in collaboration
with the scientific community, crosses the entire spectrum of health sciences. But our focus
remains singular, to bring the most effective results to the health care community and patients
worldwide.
Pherros Biosciences seeks to innovate new therapeutics in key distinct disciplines, including
diseases of the brain and central nervous system as well as aging related disorders. Brain,
central nervous system, and aging related diseases are of particular interest to Pherros
Biosciences because the pathways associated with diseases of this type largely remain a mystery
yet are expected to explode in incidence rate due to increases in longevity of the human
population.
Structural biochemistry and its relationship to function, along with cellular communication
structure-function relationships and cellular signaling are some of the critical pathways that
we examine for the targeting of our therapeutics. Pherros Biosciences also uses transformative
approaches to therapeutic candidate evaluation and development in order to reduce the time to
completion of our development programs, including through examination of human-device
interactions and the application of artificial intelligence. We have partnered with private and
public research institutions to develop candidates for development through clinical and
pre-clinical trials using all of these exciting technologies.
Pherros Biosciences is proud to be a partner in saving and improving lives.